glp-1 drugs insurance coverage MCT2D States cutting back on coverage
Description
27 The results were similar when semaglutide was compared to insulin glargine and dulaglutide, but importantly, fewer hypoglycaemic episodes were recorded with semaglutide
PubMed, Saleh, Rofida A., et al
In the Type 2 Diabetes Group, 710 patients with Type 2 diabetes were studied
Koliaki, C
